99 related articles for article (PubMed ID: 24726242)
1. A monoclonal antibody ameliorates local inflammation and osteoporosis by targeting TNF-α and RANKL.
Qian H; Yuan H; Wang J; Du Y; Zhang X; Sun Y; Li Z; Zhao W
Int Immunopharmacol; 2014 Jun; 20(2):370-6. PubMed ID: 24726242
[TBL] [Abstract][Full Text] [Related]
2. Engineering and characterization of a humanized antibody targeting TNF-α and RANKL.
Wang J; Du Y; Qian H; Yu H; Li S; Zhang X; Li Z; Yuan H; Zhao W
Biochem Biophys Res Commun; 2014 Jul; 450(1):717-22. PubMed ID: 24950406
[TBL] [Abstract][Full Text] [Related]
3. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic role of a vaccine targeting RANKL and TNF-α on collagen-induced arthritis.
Yuan H; Qian H; Liu S; Zhang X; Li S; Wang W; Li Z; Jia J; Zhao W
Biomaterials; 2012 Nov; 33(32):8177-85. PubMed ID: 22884682
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
6. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
Ock S; Ahn J; Lee SH; Park H; Son JW; Oh JG; Yang DK; Lee WS; Kim HS; Rho J; Oh GT; Abel ED; Park WJ; Min JK; Kim J
Cardiovasc Res; 2012 Apr; 94(1):105-14. PubMed ID: 22298642
[TBL] [Abstract][Full Text] [Related]
7. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody.
Kamijo S; Nakajima A; Ikeda K; Aoki K; Ohya K; Akiba H; Yagita H; Okumura K
Biochem Biophys Res Commun; 2006 Aug; 347(1):124-32. PubMed ID: 16815304
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
[TBL] [Abstract][Full Text] [Related]
11. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-α inhibits titanium particle-induced osteoclastogenesis and bone resorption.
Guo H; Zhang J; Hao S; Jin Q
Int J Mol Med; 2013 Aug; 32(2):296-306. PubMed ID: 23760678
[TBL] [Abstract][Full Text] [Related]
13. A study on inhibition of inflammation via p75TNFR signaling pathway activation in mice with traumatic brain injury.
Wang YX; You Q; Su WL; Li Q; Hu ZQ; Wang ZG; Sun YP; Zhu WX; Ruan CP
J Surg Res; 2013 Jun; 182(1):127-33. PubMed ID: 22935315
[TBL] [Abstract][Full Text] [Related]
14. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen regulates bone resorption and cytokine production in the maxillae of female mice.
Macari S; Duffles LF; Queiroz-Junior CM; Madeira MF; Dias GJ; Teixeira MM; Szawka RE; Silva TA
Arch Oral Biol; 2015 Feb; 60(2):333-41. PubMed ID: 25438102
[TBL] [Abstract][Full Text] [Related]
16. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
[TBL] [Abstract][Full Text] [Related]
17. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.
Kostenuik PJ; Nguyen HQ; McCabe J; Warmington KS; Kurahara C; Sun N; Chen C; Li L; Cattley RC; Van G; Scully S; Elliott R; Grisanti M; Morony S; Tan HL; Asuncion F; Li X; Ominsky MS; Stolina M; Dwyer D; Dougall WC; Hawkins N; Boyle WJ; Simonet WS; Sullivan JK
J Bone Miner Res; 2009 Feb; 24(2):182-95. PubMed ID: 19016581
[TBL] [Abstract][Full Text] [Related]
18. A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.
Douni E; Rinotas V; Makrinou E; Zwerina J; Penninger JM; Eliopoulos E; Schett G; Kollias G
Hum Mol Genet; 2012 Feb; 21(4):784-98. PubMed ID: 22068587
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-induced bone loss: can it be prevented?
Romas E; Gillespie MT
Rheum Dis Clin North Am; 2006 Nov; 32(4):759-73. PubMed ID: 17288976
[TBL] [Abstract][Full Text] [Related]
20. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
